Search Results - "Bitman B"

Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE Study.

Authors: Pope, Janet E. Patel, Jayeshkumar Saffore, Christopher D. et al.

Source: Rheumatology & Therapy. Aug2026, Vol. 13 Issue 4, p1075-1089. 15p.

Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study.

Authors: Gossec, Laure Baraliakos, Xenofon Galloway, James et al.

Source: Rheumatology & Therapy. Apr2026, Vol. 13 Issue 2, p347-360. 14p.

Influence of Biological Sex on Participant Characteristics, Guselkumab Efficacy and Radiographic Progression in Active Psoriatic Arthritis: Post Hoc Analysis of Three Randomized Trials.

Authors: Gladman, Dafna D. Eder, Lihi Selmi, Carlo et al.

Source: Rheumatology & Therapy. Feb2026, Vol. 13 Issue 1, p213-229. 17p.

Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year.

Authors: Thaçi, Diamant Asahina, Akihiko Boehncke, Wolf-Henning et al.

Source: Dermatology & Therapy. Feb2026, Vol. 16 Issue 2, p953-976. 24p.

Response to Tofacitinib in Patients with Psoriatic Arthritis and Probable Anxiety/Depressive Disorder: A Post Hoc Analysis of Phase 3 Trials.

Authors: Gossec, Laure Sellas, Agustí Gruben, David C. et al.

Source: Rheumatology & Therapy. Dec2025, Vol. 12 Issue 6, p1175-1186. 12p.

Upper extremity joint tenderness as a practical indicator for assessing presenteeism in rheumatoid arthritis patients: A cross-sectional observational study.

Authors: Naito, Ryota Taniguchi, Masashi Onizawa, Hideo et al.

Source: PLoS ONE. 6/5/2025, Vol. 20 Issue 6, p1-15. 15p.

Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials.

Authors: Curtis, Jeffrey R. Deodhar, Atul Soriano, Enrique R. et al.

Source: Rheumatology & Therapy. Dec2024, Vol. 11 Issue 6, p1501-1517. 17p.

Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia A.

Authors: Wu, Runhui Wang, Xiaoling Zhao, Xielan et al.

Source: Haemophilia. Nov2022, Vol. 28 Issue 6, pe199-e208. 10p. 1 Diagram, 5 Charts, 2 Graphs.

Pharmacokinetic, efficacy and safety evaluation of B‐domain‐deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A.

Authors: Xue, Feng Zhao, Xielan Sun, Jing et al.

Source: Haemophilia. Sep2021, Vol. 27 Issue 5, p814-822. 9p. 1 Diagram, 5 Charts, 1 Graph.

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial.

Authors: Kristensen, Lars Erik Keiserman, Mauro Papp, Kim et al.

Source: Rheumatology & Therapy. Jun2024, Vol. 11 Issue 3, p617-632. 16p.

Enthesitis and Dactylitis Resolution with Risankizumab for Active Psoriatic Arthritis: Integrated Analysis of the Randomized KEEPsAKE 1 and 2 Trials.

Authors: Kwatra, Shawn G. Khattri, Saakshi Amin, Ahmad Z. et al.

Source: Dermatology & Therapy. Jun2024, Vol. 14 Issue 6, p1517-1530. 14p.

Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE Study.

Authors: Chandran, Vinod Bessette, Louis Thorne, Carter et al.

Source: Rheumatology & Therapy. Apr2024, Vol. 11 Issue 2, p443-455. 13p.

Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Authors: Mease, Philip J. Young, Pamela Fallon, Lara et al.

Source: Rheumatology & Therapy. Apr2024, Vol. 11 Issue 2, p313-329. 17p.

Comprehensive Assessment of Pharmacokinetics, Pharmacodynamics, and Tolerability of Ligelizumab in Healthy Volunteers and Patients with Chronic Spontaneous Urticaria to Optimize Its Subcutaneous Delivery System.

Authors: Ji, Yan Calonder, Claudio Kirsilä, Tiina et al.

Source: Pharmaceutics. Sep2023, Vol. 15 Issue 9, p2266. 13p.

Sex Differences in Quality of Life Related to Nail Psoriasis Among Patients With Psoriatic Disease: A Cross-Sectional Study.

Authors: Guaracha-Basañez GA García-Herrera IP Mendez-Flores S et al.

Source: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [J Clin Rheumatol] 2026 Apr 01; Vol. 32 (3), pp. e69-e76. Date of Electronic Publication: 2026 Jan 30.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9518034 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-7355 (Electronic) Linking ISSN: 10761608 NLM ISO Abbreviation: J Clin Rheumatol Subsets: MEDLINE

The prediction of a good therapeutic response and outcome: at baseline or after a short term?

Authors: Kameda H Maezawa R Minegishi Y et al.

Source: Clinical rheumatology [Clin Rheumatol] 2026 Mar; Vol. 45 (3), pp. 1615-1617. Date of Electronic Publication: 2026 Jan 24.

Publication Type: Editorial

Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949 (Electronic) Linking ISSN: 07703198 NLM ISO Abbreviation: Clin Rheumatol Subsets: MEDLINE; In Process

Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study.

Authors: Woyach, Jennifer A. Barr, Paul M. Kipps, Thomas J. et al.

Source: Cancers. Jan2023, Vol. 15 Issue 2, p507. 16p.

Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial.

Authors: Michaud, Kaleb Pope, Janet E. Emery, Paul et al.

Source: Rheumatology & Therapy. Sep2019, Vol. 6 Issue 3, p409-419. 11p.

Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis.

Authors: Fleischmann, Roy M. Bock, Amy E. Zhang, Wuyan et al.

Source: Rheumatology & Therapy. Jun2022, Vol. 9 Issue 3, p839-850. 12p.

Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1.

Authors: Strand, Vibeke Mease, Philip J. Soriano, Enrique R. et al.

Source: Rheumatology & Therapy. Dec2021, Vol. 8 Issue 4, p1789-1808. 20p.